Depression in adults: recognition and management
... ICD-10, which was used in the previous guideline (NICE clinical guideline 23). This is because DSMIV is used in nearly all the evidence reviewed and it provides definitions for atypical symptoms and seasonal depression. Its definition of severity also makes it less likely that a diagnosis of depress ...
... ICD-10, which was used in the previous guideline (NICE clinical guideline 23). This is because DSMIV is used in nearly all the evidence reviewed and it provides definitions for atypical symptoms and seasonal depression. Its definition of severity also makes it less likely that a diagnosis of depress ...
For More Information Articles
... No suicides occurred in any of the pediatric trials. There were suicides in the adult trials, but the number was not sufficient to reach any conclusion about drug effect on suicide. It is unknown whether the suicidality risk extends to longer-term use, i.e., beyond several months. However, there is ...
... No suicides occurred in any of the pediatric trials. There were suicides in the adult trials, but the number was not sufficient to reach any conclusion about drug effect on suicide. It is unknown whether the suicidality risk extends to longer-term use, i.e., beyond several months. However, there is ...
Premenstrual syndrome DynaMed http://web.a.ebscohost.com
... contraceptives can be found in Obstet Gynecol 2010 Jan;115(1):206 (reaffirmed 2012 Aug) or at National Guideline Clearinghouse 2010 Jul 5:15428, commentary can be found in ACOG News Release 2009 Dec 21 Selective serotonin reuptake inhibitors (SSRIs): see antidepressants for general information SSRIs ...
... contraceptives can be found in Obstet Gynecol 2010 Jan;115(1):206 (reaffirmed 2012 Aug) or at National Guideline Clearinghouse 2010 Jul 5:15428, commentary can be found in ACOG News Release 2009 Dec 21 Selective serotonin reuptake inhibitors (SSRIs): see antidepressants for general information SSRIs ...
The Placebo Effect: the Good, the Bad, and the Ugly
... patients: “It is of the utmost imsponses are more profound when benefits for patients, while at the same portance that physicians achieve a given medication is thought to time, avoiding false conclusions. the highest possible placebo effect be more expensive than a cheaper rates. To do this, doctors ...
... patients: “It is of the utmost imsponses are more profound when benefits for patients, while at the same portance that physicians achieve a given medication is thought to time, avoiding false conclusions. the highest possible placebo effect be more expensive than a cheaper rates. To do this, doctors ...
Canadian Network for Mood and Anxiety Treatments (CANMAT) Clinical
... disorder (MDD). Guidelines for bipolar depression are included in the CANMAT guidelines for bipolar disorder (Yatham et al., 2009). Some questions include information and summary recommendations for other special populations (children and adolescents, older age, pregnant women, medical comorbidity) ...
... disorder (MDD). Guidelines for bipolar depression are included in the CANMAT guidelines for bipolar disorder (Yatham et al., 2009). Some questions include information and summary recommendations for other special populations (children and adolescents, older age, pregnant women, medical comorbidity) ...
Depression and anxiety
... may be a delay of several weeks before the person feels any benefits. There may also be side-effects to begin with, possibly more often than in a younger person, but these should lessen as the body adjusts to the drugs. If the side-effects continue, the doctor may decide to change the dose or provid ...
... may be a delay of several weeks before the person feels any benefits. There may also be side-effects to begin with, possibly more often than in a younger person, but these should lessen as the body adjusts to the drugs. If the side-effects continue, the doctor may decide to change the dose or provid ...
Background Paper 6.15 Depression
... This paper is an update of the background paper for Chapter 6.15 of the 2004 Priority Medicines for Europe and the World.1 (Published at: http://archives.who.int/prioritymeds/report/background/depression.doc.) This background paper describes demographic trends and the burden of disease of major depr ...
... This paper is an update of the background paper for Chapter 6.15 of the 2004 Priority Medicines for Europe and the World.1 (Published at: http://archives.who.int/prioritymeds/report/background/depression.doc.) This background paper describes demographic trends and the burden of disease of major depr ...
Psychopharmacology of Anxiety Disorders
... A 30‐year‐old woman presents to her PCP c/o of daily headaches, muscle tension, diarrhea and difficulty sleeping. She states that her husband says she is a “worry wart” and she admits that she has difficulty controlling her anxiety over her financial situation, job security, and the safety of ...
... A 30‐year‐old woman presents to her PCP c/o of daily headaches, muscle tension, diarrhea and difficulty sleeping. She states that her husband says she is a “worry wart” and she admits that she has difficulty controlling her anxiety over her financial situation, job security, and the safety of ...
childhood and adolescent depression
... masked depression in which depression is manifest in several different ways than that of adults. There is also the belief that depression emerges as a part of normal development. This view states that there are characteristics of depression such as tantrums and fears that are common over the course ...
... masked depression in which depression is manifest in several different ways than that of adults. There is also the belief that depression emerges as a part of normal development. This view states that there are characteristics of depression such as tantrums and fears that are common over the course ...
Section E MOOD DISORDERS
... Gene-environment interaction: the serotonin transporter gene, childhood maltreatment and depression. New Zealand’s Dunedin Health and Development Study followed a cohort of 1,037 children from 3 to 26 years of age carefully tracking the development of psychiatric disorders, serious life events and o ...
... Gene-environment interaction: the serotonin transporter gene, childhood maltreatment and depression. New Zealand’s Dunedin Health and Development Study followed a cohort of 1,037 children from 3 to 26 years of age carefully tracking the development of psychiatric disorders, serious life events and o ...
Herbal and Dietary Supplements for Treatment of Anxiety Disorders
... Use of complementary and alternative medicine has increased over the past decade. A variety of studies have suggested that this use is greater in persons with symptoms or diagnoses of anxiety and depression. Data support the effectiveness of some popular herbal remedies and dietary supplements; in s ...
... Use of complementary and alternative medicine has increased over the past decade. A variety of studies have suggested that this use is greater in persons with symptoms or diagnoses of anxiety and depression. Data support the effectiveness of some popular herbal remedies and dietary supplements; in s ...
World Federation of Societies of Biological Psychiatry (WFSBP
... who fail to remain well on either drug alone the combination of antidepressant and lithium is indicated. Many patients receive antidepressants during the acute and continuation phase, and the best treatment recommendation to prevent recurrence of depression is to continue this medication at the same ...
... who fail to remain well on either drug alone the combination of antidepressant and lithium is indicated. Many patients receive antidepressants during the acute and continuation phase, and the best treatment recommendation to prevent recurrence of depression is to continue this medication at the same ...
Generalized Anxiety Disorder
... DSM-IV GAD Diagnostic Criteria • Excessive or difficult to control worry and anxiety •More days than not for 6 months* •6-month duration affects prevalence but not course or disability.* Increasingly controversial ...
... DSM-IV GAD Diagnostic Criteria • Excessive or difficult to control worry and anxiety •More days than not for 6 months* •6-month duration affects prevalence but not course or disability.* Increasingly controversial ...
World Federation of Societies of Biological Psychiatry
... clearly indicated in situations associated with a high risk of recurrence. For patients who have had three or more episodes of major depression, and in patients with a high prior rate of recurrence (e.g., two episodes within five years), longer term maintenance therapy is indicated. Duration may var ...
... clearly indicated in situations associated with a high risk of recurrence. For patients who have had three or more episodes of major depression, and in patients with a high prior rate of recurrence (e.g., two episodes within five years), longer term maintenance therapy is indicated. Duration may var ...
Depression - Mason Payne Final Project
... having lots of energy, having racing thoughts and little need for sleep, talking fast, having difficulty focusing on tasks, and feeling frustrated and irritable. This is not just a fleeting experience. Sometimes the person loses touch with reality and has episodes of psychosis. Experiencing psychosi ...
... having lots of energy, having racing thoughts and little need for sleep, talking fast, having difficulty focusing on tasks, and feeling frustrated and irritable. This is not just a fleeting experience. Sometimes the person loses touch with reality and has episodes of psychosis. Experiencing psychosi ...
World Federation of Societies of Biological Psychiatry (WFSBP)
... the focus of the recommendations developed in these guidelines. A major depressive episode can be further divided into categories according to its severity (mild, moderate, and severe). 1.2 Goal and target audience of WFSBP guidelines These WFSBP guidelines provide an update of contemporary knowledg ...
... the focus of the recommendations developed in these guidelines. A major depressive episode can be further divided into categories according to its severity (mild, moderate, and severe). 1.2 Goal and target audience of WFSBP guidelines These WFSBP guidelines provide an update of contemporary knowledg ...
The Risks and Benefits of Selective Serotonin Reuptake Inhibitors
... reuptake inhibitors, OR SSRI*, OR adolescen*. Other search terms used include anxiety disorder in child* and adol*, not med*, teach* or educate*, and treatment*, education OR teaching OR counseling, pediatric*, OR adverse, OR side effects, OR drug effects, OR effective. The results were limited to t ...
... reuptake inhibitors, OR SSRI*, OR adolescen*. Other search terms used include anxiety disorder in child* and adol*, not med*, teach* or educate*, and treatment*, education OR teaching OR counseling, pediatric*, OR adverse, OR side effects, OR drug effects, OR effective. The results were limited to t ...
Depression and anxiety
... There is some evidence that sessions of talking therapy, given over several weeks, reduce depression and anxiety in people with dementia, particularly in the early stages of the condition. The therapy usually needs to be modified to suit the person’s level of communication, understanding and memory ...
... There is some evidence that sessions of talking therapy, given over several weeks, reduce depression and anxiety in people with dementia, particularly in the early stages of the condition. The therapy usually needs to be modified to suit the person’s level of communication, understanding and memory ...
mood disorders
... depression and antidepressants increase their concentration. However, the monoamine depletion theories cannot explain why drugs, such as cocaine, which enhance 5-HT and NE transmission, are ineffective in treating depression. In addition, they also do not explain how a drug that is a relatively weak ...
... depression and antidepressants increase their concentration. However, the monoamine depletion theories cannot explain why drugs, such as cocaine, which enhance 5-HT and NE transmission, are ineffective in treating depression. In addition, they also do not explain how a drug that is a relatively weak ...
Linköping University Post Print Implementation of Internet-based preventive
... professional support or if they work without any guidance. In case support is necessary, it is not clear which level of support is needed. This study examines whether an internet-based self-help intervention with a coach is more effective than the same intervention without a coach in terms of clinic ...
... professional support or if they work without any guidance. In case support is necessary, it is not clear which level of support is needed. This study examines whether an internet-based self-help intervention with a coach is more effective than the same intervention without a coach in terms of clinic ...
Mood Disorders: Depression
... has a negative effect on the disease course. Comorbidity has been shown to result in a higher rate of suicide, greater severity of depression, greater impairment in social and occupational functioning, and poorer response to treatment (Simon & Rosenbaum, 2003). The incidence of major depression grea ...
... has a negative effect on the disease course. Comorbidity has been shown to result in a higher rate of suicide, greater severity of depression, greater impairment in social and occupational functioning, and poorer response to treatment (Simon & Rosenbaum, 2003). The incidence of major depression grea ...
Evidence-based guidelines for treating depressive disorders with antidepressants: A revision Guidelines
... NNTs may, however, be clinically relevant in the context of more severe and/or treatment-resistant depression. Therefore the assessment of clinical significance depends on context and this needs to be judged in individual situations. In addition, the outcome measures used are ratings of depressive s ...
... NNTs may, however, be clinically relevant in the context of more severe and/or treatment-resistant depression. Therefore the assessment of clinical significance depends on context and this needs to be judged in individual situations. In addition, the outcome measures used are ratings of depressive s ...
Diagnosing and Treating Depression - GHC-SCW
... third trimester (24-32 weeks), and at six weeks postpartum.14-17(UW Health Low quality evidence, strong recommendation) Screening may be completed using the Edinburgh Postnatal Depression Scale (EPDS), Patient Health Questionnaire-9 (PHQ-9) or Patient Health Questionnaire-A (PHQ-A) assessment tools. ...
... third trimester (24-32 weeks), and at six weeks postpartum.14-17(UW Health Low quality evidence, strong recommendation) Screening may be completed using the Edinburgh Postnatal Depression Scale (EPDS), Patient Health Questionnaire-9 (PHQ-9) or Patient Health Questionnaire-A (PHQ-A) assessment tools. ...
Treatment guidelines for bipolar disorder: A critical review
... lithium, divalproex sodium or olanzapine is generally recommended. At latter stages combination therapy is strongly recommended. It is clearly stated that in bipolar depression antidepressants should be used only in combination with antimanic agents in order to avoid switching of phases. During the ...
... lithium, divalproex sodium or olanzapine is generally recommended. At latter stages combination therapy is strongly recommended. It is clearly stated that in bipolar depression antidepressants should be used only in combination with antimanic agents in order to avoid switching of phases. During the ...
Antidepressant
Antidepressants are drugs used for the treatment of major depressive disorder and other conditions, including dysthymia, anxiety disorders, obsessive compulsive disorder, eating disorders, chronic pain, neuropathic pain and, in some cases, dysmenorrhoea, snoring, migraine, attention-deficit hyperactivity disorder (ADHD), addiction, dependence, and sleep disorders. They can be used alone or in combination with other medications but only when prescribed.The most important classes of antidepressants are the selective serotonin reuptake inhibitors (SSRIs), serotonin–norepinephrine reuptake inhibitors (SNRIs), tricyclic antidepressants (TCAs), monoamine oxidase inhibitors (MAOIs), reversible monoamine oxidase A inhibitors (rMAO-A inhibitors), tetracyclic antidepressants (TeCAs), and noradrenergic and specific serotonergic antidepressant (NaSSAs). St John's wort is also used in the treatment of depression.